Member Info for RichMacintyre

Market blown away by the results!

Oh behave, this outfit dont even own A42, they have to buy it first, good luck with that. Richy warned you all what was coming, an AI company with no AI is not a company.

Almost criminal! Peter Redmond does not deserve these options! Dr Sandler has earned them but the rest can go and whistle!

Oh behave, met some of you at sharestock last year hopefully do the same this! we might share a pint but we are not friends and I am no longer paid to pump trash like this. I will happily burn the shills now, we all know the future for Avacta and its not pretty! Faron and Hemogenyx are my long picks and Avacta go short. Faron looking good soon but Hemogenyx should move first.

Just more churn before the next CLN conversion, follow Richy if you want to get rich, avoid this one like the plague, even the rampers have given up, surprised its blue!

On the leaders board so decided to have a look, Louis Ching has a controlling stake? Not worth the risk this one, with such a controlling interest if this company ever takes off would be too easy to wipe out small shareholders. CLNs have conversion of 0.3p funny how SP dropped to around here.... Richy smells something fishy, expect to see a CLN Conversion note in the next few days. Dont be surprised if the CLN terms are varied to drop conversion price.

Behave Nero!!! Its not an opportunity, everyone wants out of this dog, I told the lot of you with your ramping that this company has nothing going for it except some idiot shareholders who cant read the writing on the wall. Where is your saviour Trojan now? anyone stupid enough to buy this deserves to lose. No compute, paying over the odds to burn tokens instead of going direct to a legit AI company, open your eyes. Should have listened to me months ago, if you think this is going to bounce? On what? some author domain name they dont even own? BEHAVE!

Oh behave yourself with trade secret nonsense, Hemogenyx are not working on the manhatten project, they protect IP which I would hope is well known and understood by industry and the FDA. Over the past 2 days my partners agreed to increase our exposure here given the opportunity the recent selling has presented. I had the chance to speak to company brokers today and was assured everything is moving ahead, slower than expected but moving. I hope they move faster, I have already held considerably longer than planned.

Should have listened to Richy, warned you this was heading one way!

Oh behave yourself, get back in your box, I have correctly called most shares over the years and many who have followed me have made a lot of money. I know when to spot a dodgy company and when to spot an opportunity! I sold most of my Hemogenyx position when the placing landed but not all and have started scaling back in,nfor obvious reasons I dont want to pass comment until I have finished buying. However if you want to compare you arrive at the crux of the issue, Hemogenyx raised £3mio at market price which appears to just go into the bank, Avacta are simply furnishing debt.

You sir I suggest should learn some manners, I suggest I hit a nerve, perhaps you need to reduce your exposure instead of overreacting to people giving their opinion.

Boy you need to return to school or perhaps you should sign up for capai and have it author your posts, choose the queens English instead of garbage so we can read it.

Thank you for your reply being a conversation, unusual and a refreshing change.

I do not like CLN instruments as a rule, I view them as guaranteed dilution which only goes to furnish the debt and not add additional funding to the company. Risk without reward if you like, I will say no more, your manner should be respected, good day sir.

Shocking! retail offer with no positive news just an invitation to dump after institutional forward selling.

I am tempted to take a position back here again on the next dip closer to 40, no rush!

Avacta remains a classic biotech cash incinerator riddled with dilution and overhang risks. With over 450 million shares now in issue and a chunky ~£19-20m convertible loan note (CLN) facility still hanging over the register—convertible at a 75p cap—the company can (and does) keep printing shares to service debt and fund its money-losing operations.

Revenue is negligible (often under £1m in core operations), losses are massive (£25-50m+ annually in recent years), and the balance sheet relies on repeated placings, open offers, and CLN conversions that relentlessly erode shareholder value.

Despite the pre|CISION platform hype and occasional clinical updates, the business burns cash with no clear path to profitability or meaningful partnerships, leaving it chronically dependent on dilutive financing in a tough market for unprofitable biotechs. At a ~£350-400m market cap, the setup screams further downside as more CLN amortizations hit, shares get issued at discounts, and the overhang weighs on any attempted rallies. This is a value trap for anyone hoping for a clean re-rating.

Oh stop this nonsense. your inventing a market that does not exist. What this outfit are trying to sell a 14 year old could vibe on cursor in a few days. Some premium platform that wraps chatgpt. Before you embarrass yourself further go and pay for a premium plan for one of the big AI platforms and have it write a novel with you. Then decide if your willing to pay double for a pretty website to sit in front and hide the interface.

Its a shame you cant short this dog and make some money on the way down, but people like you need to behave and stop the gaslighting.

Stop it, behave yourself! this company own nothing, they have no compute and would have to give away more than 100% equity to secure anything. They have no compute so they would only be getting a wrapper. I almost feel sorry for some people but some should hang their head in shame trying to pretend there is some secret hidden gem here.

Oh behave and stop flogging this dead horse.

First page of google is all that matters and in AI if you dont own the compute your nothing. Token costs will destroy any profit this white label wrapper hope to make. Should have listened when you were warned, right again!

Yes, put it in the bottom drawer and accept you have lost it thats a good plan!

I told you this share was on a road to nowhere, without their own compute your paying a premium to a middle man instead of going direct to the supplier, works when its hard to go to the supplier not with ai!

I was right again on this one, you need to protect your capital and not chase unicorns.

Stop this foolishness. stop it, this company has no server farm, no compute, no ex mining farm, they buy tokens from actual AI companies. Nobody here things Capai is going to compete with google vio do you? Author42 is a joke, any free AI chat gives you that for free. The actual AI companies are spending millions on cpus and ram and gpus. This outfit want to resell that and charge a premium. its dead. anyone promoting this needs to stop and behave themselves.